The Protein Brewery recently secured €30 million in Series B funding, shortly after its mycelium ingredient, Fermotein, became the first novel mycoprotein to receive EU Novel Food approval. The €30 million Series B funding, announced by AgFunderNews and FoodBev, positions Fermotein as a significant player among emerging plant-based protein sources for 2026. The approval from the European Union validates a new class of alternative proteins, marking a critical moment for the company's expansion plans.
The alternative protein market has long relied on established sources like soy and pea, but a novel fungal protein has just achieved significant regulatory and financial breakthroughs, challenging the status quo. Significant regulatory and financial breakthroughs for a novel fungal protein indicate a shift in consumer and investor interest towards more diversified and sustainably produced protein options beyond traditional plant-based offerings. The tension between entrenched ingredients and innovative alternatives is now more pronounced.
Mycelium-based proteins are likely to capture a substantial and rapidly growing share of the alternative protein market, driving further innovation and diversification in the food industry. Fermotein's unique nutritional profile and its validated regulatory pathway support this trajectory, setting a new standard for what novel ingredients can achieve. The market is increasingly seeking alternatives that offer both nutritional completeness and environmental advantages.
1. Fermotein's Comprehensive Nutritional Profile
Fermotein contains approximately 50% complete protein with all essential amino acids, according to Food Ingredients First. The 50% complete protein content, comparable to animal proteins, provides a robust nutritional foundation for various food applications. The presence of all essential amino acids ensures that Fermotein can serve as a primary protein source in diets, addressing concerns about nutritional adequacy often associated with some plant-based alternatives.
Furthermore, this mycelium ingredient also contains 30% fiber, a significant amount that contributes to digestive health and satiety. The combination of high complete protein and substantial fiber positions Fermotein as a nutritionally comprehensive alternative that could surpass the functional benefits of many existing plant-based proteins. Consumers are increasingly seeking ingredients that offer multiple health benefits beyond just protein content.
